Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Acadia Pharmaceuticals buy Canaccord Genuity Group Inc.

Start price
€22.65
15:45 / 50%
Target price
€31.62
29.06.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 29.06.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time.
Performance without dividends (%)
Name 1w
Acadia Pharmaceuticals -
iShares Core DAX® -1.358%
iShares Nasdaq 100 -3.700%
iShares Nikkei 225® -2.512%
iShares S&P 500 -1.662%

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -
Target price 31.622
Change
Ends at 29.06.27

ACADIA Pharmaceuticals (ACAD) had its price target raised by Canaccord Genuity Group Inc. from $32.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat